According to a pilot study of 20 people conducted at the University of Minnesota, daily doses of a compound called arabinogalactan over a period of 6 months resulted in a significant increase in the beneficial lactobacillus species of bacteria. Why can’t it be concluded that the compound is beneficial for the majority of people?